These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer. Perkins JB; Effenbein GJ; Fields KK Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448 [TBL] [Abstract][Full Text] [Related]
29. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results]. Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464 [TBL] [Abstract][Full Text] [Related]
30. Cytotoxic drugs, collection of stem cells and hematologic recovery after autologous transplantation. Schmitz N Haematologica; 2005 Jan; 90(1):4-5. PubMed ID: 15644304 [No Abstract] [Full Text] [Related]
31. High-dose treatment with autologous stem cell transplantation versus sequential chemotherapy: the GELA experience. Bosly A; Haioun C; Gisselbrecht C; Reyes F; Coiffier B Eur J Haematol Suppl; 2001 Jul; 64():3-7. PubMed ID: 11486398 [TBL] [Abstract][Full Text] [Related]
32. High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults. Douer D; Levine A; Anderson WF; Gordon M; Groshen S; Khan A; Mohrbacher A; Muggia F; Shibata D Hum Gene Ther; 1996 Mar; 7(5):669-84. PubMed ID: 8845392 [No Abstract] [Full Text] [Related]
33. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Williams SF; Bitran JD; Richards JM; DeChristopher PJ; Orlina AR Prog Clin Biol Res; 1990; 333():461-9. PubMed ID: 1968650 [No Abstract] [Full Text] [Related]
35. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients. Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627 [TBL] [Abstract][Full Text] [Related]
37. The role of autologous stem cell transplantation in the management of multiple myeloma. Fermand JP; Brechignac S Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889 [TBL] [Abstract][Full Text] [Related]
38. [Cellular therapies in 2002]. Bregni M Tumori; 2002; 88(6):A20-4. PubMed ID: 12597161 [No Abstract] [Full Text] [Related]